A month has gone by since the last earnings report for Idexx Laboratories (IDXX). Shares have lost about 0.4% in that time frame, underperforming the S&P 500. But investors have to be wondering, will ...

Michael Erickson, PhD, to Succeed Jay Mazelsky as President and CEO; Mazelsky to Serve as Executive Chair of the Board of Directors Dr. Erickson brings nearly two decades of leadership experience and ...

Good morning, and welcome to the IDEXX Laboratories Third Quarter 2024 Earnings Conference Call. As a reminder, today's conference is being recorded. Participating in the call this morning are Jay ...

Idexx LaboratoriesIDXX is the IBD Stock of the Day for Friday. Shares of the maker of animal diagnostics tools are trading within a flat base following a strong run late last year. The Maine-based ...

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. The popular research ...

Idexx delivered revenue and EPS growth of 6% and 13% in Q4, but its guidance appears to have caught the market's attention. Looking ahead to 2025, management expects the company to grow sales by 4% to ...

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced that the Company’s Board of Directors authorized an increase in its ongoing share repurchase ...

Michael Erickson, PhD, to Succeed Jay Mazelsky as President and CEO; Mazelsky to Serve as Executive Chair of the Board of Directors IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet ...

Michael Erickson, PhD, to Succeed Jay Mazelsky as President and CEO; Mazelsky to Serve as Executive Chair of the Board of Directors “Mike’s appointment as the Company’s next President and CEO is the ...